Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |